StockData
MannKind Corp logo

MannKind Corp (MNKD) stock

MNKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30127% above fair value
$4.07+0.00 (0.00%)

Close on Nov 18, 2026Market cap $1.31BP/E –Yield –

MannKind revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

MannKind's revenue for the twelve months ending Jun 30, 2026 was $393.63M, up 30.5% year over year. For fiscal 2025 it was $348.97M, up 22.2% from the year before. The highest annual figure on record is $348.97M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$348.97M+22.2%
FY2024Dec 31, 2024$285.50M+43.5%
FY2023Dec 31, 2023$198.96M+99.4%
FY2022Dec 31, 2022$99.77M+32.2%
FY2021Dec 31, 2021$75.44M+15.8%
FY2020Dec 31, 2020$65.14M+3.3%
FY2019Dec 31, 2019$63.04M+126.3%
FY2018Dec 31, 2018$27.86M+137.2%
FY2017Dec 31, 2017$11.75M-93.3%
FY2016Dec 31, 2016$174.76M–
FY2015Dec 31, 2015$0–
FY2014Dec 31, 2014$0–
FY2013Dec 31, 2013$0-100.0%
FY2012Dec 31, 2012$35.00K-30.0%
FY2011Dec 31, 2011$50.00K-46.2%
FY2010Dec 31, 2010$93.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$109.37M+42.9%
Q1 FY2026Mar 31, 2026$90.17M+15.1%
Q4 FY2025Dec 31, 2025$111.96M+45.8%
Q3 FY2025Sep 30, 2025$82.13M+17.2%
Q2 FY2025Jun 30, 2025$76.53M+5.7%
Q1 FY2025Mar 31, 2025$78.35M+18.2%
Q4 FY2024Dec 31, 2024$76.78M+31.3%
Q3 FY2024Sep 30, 2024$70.08M+36.7%
Q2 FY2024Jun 30, 2024$72.39M+48.9%
Q1 FY2024Mar 31, 2024$66.26M+63.1%
Q4 FY2023Dec 31, 2023$58.47M+62.2%
Q3 FY2023Sep 30, 2023$51.25M+56.1%
Q2 FY2023Jun 30, 2023$48.61M+157.3%
Q1 FY2023Mar 31, 2023$40.63M+238.8%
Q4 FY2022Dec 31, 2022$36.06M+188.1%
Q3 FY2022Sep 30, 2022$32.83M+47.8%
Q2 FY2022Jun 30, 2022$18.89M-18.8%
Q1 FY2022Mar 31, 2022$11.99M-31.2%
Q4 FY2021Dec 31, 2021$12.52M-32.1%
Q3 FY2021Sep 30, 2021$22.21M+44.7%
Q2 FY2021Jun 30, 2021$23.28M+54.0%
Q1 FY2021Mar 31, 2021$17.44M+7.4%
Q4 FY2020Dec 31, 2020$18.44M+15.3%
Q3 FY2020Sep 30, 2020$15.35M+5.2%
Q2 FY2020Jun 30, 2020$15.11M+0.7%
Q1 FY2020Mar 31, 2020$16.24M-7.0%
Q4 FY2019Dec 31, 2019$15.99M-0.2%
Q3 FY2019Sep 30, 2019$14.60M+226.6%
Q2 FY2019Jun 30, 2019$15.00M+285.4%
Q1 FY2019Mar 31, 2019$17.45M+403.5%
Q4 FY2018Dec 31, 2018$16.03M+253.9%
Q3 FY2018Sep 30, 2018$4.47M+118.7%
Q2 FY2018Jun 30, 2018$3.89M+80.0%
Q1 FY2018Mar 31, 2018$3.47M+15.2%
Q4 FY2017Dec 31, 2017$4.53M-63.5%
Q3 FY2017Sep 30, 2017$2.04M-98.7%
Q2 FY2017Jun 30, 2017$2.16M–
Q1 FY2017Mar 31, 2017$3.01M–
Q4 FY2016Dec 31, 2016$12.40M–
Q3 FY2016Sep 30, 2016$162.35M–

More MannKind figures

See a number that looks wrong?